, SP-Brazil Acute Myocardial Infarction in Progressively Elderly Patients . A Comparative Analysis of Immediate Results in Patients who Underwent Primary Percutaneous Coronary Intervention

Results We analyzed 201 patients with age ranging from 60 to 93 years, who underwent primary PCI. Patients with ages above 70 were more often female (p=.015). Those with ages above 80 were treated later with PCI (p=.054), and all of them presented with total occlusion of the infarctrelated artery. Coronary stents were implanted in 30% of the patients. Procedural success was lower in >80 year old patients (p=.022), and the death rate was higher in >70 years olds (p=.019). Reinfarction and coronary bypass surgery were uncommon events. A trend occurred toward a higher combined incidence of major in-hospital events according to increased age (p=.064).

[1]  N. Powe,et al.  Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. , 2000, Circulation.

[2]  Bruce R. Brodie,et al.  Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction , 1999 .

[3]  H. White.  Future of reperfusion therapy for acute myocardial infarction , 1999, The Lancet.

[4]  Ayah E. Johnson,et al.  Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients. , 1999, JAMA.

[5]  R. Califf,et al.  Effect of age on outcome with primary angioplasty versus thrombolysis. , 1999, Journal of the American College of Cardiology.

[6]  J. Wardrope,et al.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. , 1999, Journal of accident & emergency medicine.

[7]  G Barbash,et al.  Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. , 1999, Lancet.

[8]  A. Kastrati,et al.  Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. , 1998, Circulation.

[9]  J. Burchenal,et al.  Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. , 1998, Circulation.

[10]  Luiz Fernando Leite Tanajura,et al.  EMPREGO DA ANGIOPLASTIA CORONÁRIA PRIMÁRIA NO INFARTO AGUDO DO MIOCÁRDIO EM PACIENTES ACIMA DE 70 ANOS , 1998 .

[11]  K. Lee,et al.  Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. , 1996, Circulation.

[12]  S. Paul,et al.  Geriatric patients with acute myocardial infarction: Cardiac risk factor profiles, presentation, thrombolysis, coronary interventions, and prognosis. , 1996, American Heart Journal.

[13]  J. O’Keefe,et al.  Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail. , 1995, Journal of the American College of Cardiology.

[14]  J. O’Keefe,et al.  Primary angioplasty for acute myocardial infarction in 1,000 consecutive patients. Results in an unselected population and high-risk subgroups. , 1993, The American journal of cardiology.

[15]  P. Kudenchuk,et al.  Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group. , 1991, Journal of the American College of Cardiology.